Inflection Point Acquisition Corp. VIII
IPHXW · NASDAQ
IPHXW key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 22.27K
- Volume
- 1.91K
- Open price
- $0.45
- High today
- $0.4001
- Low today
- $0.40
- 52 Week high
- $0.47
- 52 Week low
- $0.38
Inflection Point Acquisition Corp. VIII (IPHXW) at a glance
As of Oct 28, 2026, Inflection Point Acquisition Corp. VIII (IPHXW) shares are priced at $0.40, giving the company a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.40 and $0.4001. The current price is 0.0% above the day's low and 0.0% below its high.
Volume so far is 1.91K shares, below the average of 22.27K shares a day.
Over the past year Inflection Point Acquisition Corp. VIII has ranged from $0.38 to $0.47, and now sits 22% of the way up that range.
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- DVLTDatavault AI$0.0879+31.19%
- RCTRedCloud Holdings$0.0617−5.95%
- TIPSTianrong Internet Products & Services$0.0014+27.27%
- GTVHGolden Triangle Ventures$0.0002+0.00%
- AITXArtificial Intelligence Technology Solutions$0.0005−43.75%
- CDTCDT Equity$0.083+3.75%
- EARIEntertainment Arts Research$0.0002+0.00%
- NBNDNetBrands$0.0006−14.29%
- NVDGraniteShares ETF Trust$4.01+2.04%
- STLAStellantis N.V$4.68+13.04%
- NTRRNeutra$0.0002+0.00%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.97−0.05%
- LYCALycia Therapeutics$25.05−4.06%
- DAVIDAVION HEALTHCARE$3.29+9.67%
- TCXBTCGX Acquisition Corp. II$10.27−0.10%
- CTYCITY THERAPEUTICS$21.65+3.79%
- IAMIambic Therapeutics$14.78+5.57%
- AMROAmaero$5.86−2.98%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.23−0.49%
- TRXBTRex Bio$14.43+4.64%
- RTSNRetension Pharmaceuticals$13.09−3.18%
- PAXGUPine Tree Acquisition$10.02+0.20%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.